drugset / Trial / NCT02905695

Post-partum Perineal Pain - Chirocaine®

NCT02905695

Phase 4 Completed 110 enrolled Hopital Foch
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this placebo-controlled clinical trial is to assess the effectiveness of the local infiltration of the analgesic Chirocaïne® on perineal pain after episiotomy or first-degree tear. The pain intensity is measured in immediate postpartum period by using a numerical rating scale (NRS) at the following times: H2, H4, H8, H12, H24, H36, H48 during rest, defecation and during activities. The safety of Chirocaïne® and the patient satisfaction are also evaluated at each time.

Timeline

Start
2011-01
Primary completion
2015-01
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified Other

Indications

No indication recorded.